Alyeska Investment Group’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,286
Closed -$80K 570
2016
Q4
$80K Buy
10,286
+82
+0.8% +$638 ﹤0.01% 435
2016
Q3
$214K Buy
10,204
+406
+4% +$8.52K ﹤0.01% 422
2016
Q2
$260K Buy
9,798
+199
+2% +$5.28K ﹤0.01% 403
2016
Q1
$354K Buy
9,599
+297
+3% +$11K ﹤0.01% 362
2015
Q4
$413K Buy
9,302
+537
+6% +$23.8K ﹤0.01% 349
2015
Q3
$682K Buy
8,765
+2,386
+37% +$186K 0.01% 402
2015
Q2
$759K Buy
6,379
+104
+2% +$12.4K 0.01% 402
2015
Q1
$864K Buy
+6,275
New +$864K 0.01% 416